Insights

Recent Acquisitions NeoTX Therapeutics LTD has recently acquired InterX, indicating a focus on growth and expansion. Leveraging this acquisition as an entry point, sales professionals could explore cross-selling opportunities to the newly integrated customer base.

Strong Financial Backing With a funding of $45 million and a revenue range of $0-10 million, NeoTX is financially stable. This presents an opportunity for sales representatives to negotiate larger contracts and partnerships confidently, assuring customers of the company's long-term viability.

Patented Technology Pipeline NeoTX's focus on building a patented, proprietary product pipeline indicates a commitment to innovation. Sales teams can leverage this unique technology stack to differentiate the company's offerings in the market, attracting clients looking for cutting-edge solutions.

Focused Biotechnology Research Operating in the biotechnology research industry with a specialization in oncology immunotherapy, NeoTX has a clear focus area. Sales professionals can capitalize on this specialized expertise to target pharmaceutical companies and research institutions seeking tailored solutions in this domain.

Market Expansion Strategy NeoTX's strategic collaborations and license agreements showcase a proactive approach to expanding market reach. Sales development representatives can align their outreach efforts with NeoTX's expansion strategy to tap into new customer segments and geographies effectively.

NeoTX Therapeutics LTD Tech Stack

NeoTX Therapeutics LTD uses 8 technology products and services including Google Analytics, Google Font API, Chart.js, and more. Explore NeoTX Therapeutics LTD's tech stack below.

  • Google Analytics
    Analytics
  • Google Font API
    Font Scripts
  • Chart.js
    Javascript Graphics
  • jQuery
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • HTTP/3
    Miscellaneous
  • PHP
    Programming Languages
  • Twenty Twenty
    Web Platform Extensions

Media & News

NeoTX Therapeutics LTD's Email Address Formats

NeoTX Therapeutics LTD uses at least 1 format(s):
NeoTX Therapeutics LTD Email FormatsExamplePercentage
First@neotx.comJohn@neotx.com
76%
FirstL@neotx.comJohnD@neotx.com
12%
Last@neotx.comDoe@neotx.com
6%
FirstL@neotx.comJohnD@neotx.com
6%

Frequently Asked Questions

Where is NeoTX Therapeutics LTD's headquarters located?

Minus sign iconPlus sign icon
NeoTX Therapeutics LTD's main headquarters is located at 2 Pekeris St. Rehovot, Israel 7670202 IL. The company has employees across 2 continents, including AsiaNorth America.

What is NeoTX Therapeutics LTD's official website and social media links?

Minus sign iconPlus sign icon
NeoTX Therapeutics LTD's official website is neotx.com and has social profiles on LinkedIn.

How much revenue does NeoTX Therapeutics LTD generate?

Minus sign iconPlus sign icon
As of July 2024, NeoTX Therapeutics LTD's annual revenue reached $3.8M.

What is NeoTX Therapeutics LTD's SIC code NAICS code?

Minus sign iconPlus sign icon
NeoTX Therapeutics LTD's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does NeoTX Therapeutics LTD have currently?

Minus sign iconPlus sign icon
As of July 2024, NeoTX Therapeutics LTD has approximately 22 employees across 2 continents, including AsiaNorth America. Key team members include Chief Financial Officer Operations: R. H.Chief Scientific Officer – Discovery Division At Neotx: D. B.Chief Medical Officer: S. F.. Explore NeoTX Therapeutics LTD's employee directory with LeadIQ.

What industry does NeoTX Therapeutics LTD belong to?

Minus sign iconPlus sign icon
NeoTX Therapeutics LTD operates in the Biotechnology Research industry.

What technology does NeoTX Therapeutics LTD use?

Minus sign iconPlus sign icon
NeoTX Therapeutics LTD's tech stack includes Google AnalyticsGoogle Font APIChart.jsjQueryjQuery MigrateHTTP/3PHPTwenty Twenty.

What is NeoTX Therapeutics LTD's email format?

Minus sign iconPlus sign icon
NeoTX Therapeutics LTD's email format typically follows the pattern of . Find more NeoTX Therapeutics LTD email formats with LeadIQ.

How much funding has NeoTX Therapeutics LTD raised to date?

Minus sign iconPlus sign icon
As of July 2024, NeoTX Therapeutics LTD has raised $45M in funding. The last funding round occurred on Feb 19, 2020 for $45M.

When was NeoTX Therapeutics LTD founded?

Minus sign iconPlus sign icon
NeoTX Therapeutics LTD was founded in 2015.
NeoTX Therapeutics LTD

NeoTX Therapeutics LTD

Biotechnology ResearchIsrael, Israel11-50 Employees

NeoTX is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy. 
With a strong research and development team, our strategy is to build a patented, proprietary and unique product pipeline to capitalize on technologies that NeoTX is developing independently and through  collaborative partnerships and license agreements.

Section iconCompany Overview

Headquarters
2 Pekeris St. Rehovot, Israel 7670202 IL
Website
neotx.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $45M

    NeoTX Therapeutics LTD has raised a total of $45M of funding over 4 rounds. Their latest funding round was raised on Feb 19, 2020 in the amount of $45M.

  • $10M

    NeoTX Therapeutics LTD's revenue is in the range of $10M

Section iconFunding & Financials

  • $45M

    NeoTX Therapeutics LTD has raised a total of $45M of funding over 4 rounds. Their latest funding round was raised on Feb 19, 2020 in the amount of $45M.

  • $10M

    NeoTX Therapeutics LTD's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.